| 1 |
Lacy BE, Weiser K, Chertoff J, et al.The diagnosis of gastroesophageal reflux disease[J]. Am J Med, 2010, 123(7): 583-592.
|
| 2 |
Katz PO, Gerson LB, Vela MF.Guidelines for the diagnosis and management of gastroesophageal reflux disease[J]. Am J Gastroenterol, 2013(3), 108: 308-328.
|
| 3 |
Vakil N, van Zanten SV, Kahrilas P, et al.The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8): 1900-1920.
|
| 4 |
Joel Heidelbaugh.Gastroesophageal Reflux Disease(GERD)[S]. Faculty Group Practice Quality Management Program of University of Michigan, 2012 May.
|
| 5 |
Ebell MH.Diagnosis of gastroesophageal reflux disease[J]. Am Fam Physician, 2010, 81(10): 1278.
|
| 6 |
Heidelbaugh JJ, Nostrant TT, Kim C, et al.Joel Heidelbaugh, Timothy Nostrant, Management of gastroesophageal reflux disease[J]. Am Fam Physician, 2003, 68(7): 1311-1318.
|
| 7 |
Standards of Practice Committee, Lichtenstein DR, Cash BD, et al.Role of endoscopy in the management of GERD[J]. Gastrointest Endosc, 2007, 66(2): 219-224.
|
| 8 |
Toghanian S, Wahlqvist P, Johnson DA, et al.The burden of disrupting gastroesophageal reflux disease: a database study in US and European cohorts[J]. Clin Drug Inves, 2010, 30(3): 167-178.
|
| 9 |
Jones R, Junghard O, Dent J, et al.Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care[J]. Aliment Pharmacol Ther, 2009, 30(10): 1030-1038.
|
| 10 |
Meineche-Schmidt V, Christensen E, Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial[J]. Am J Gastroenterol, 2000, 95(10): 2777-2783.
|
| 11 |
Chassany O, Shaheen NJ, Karlsson M, et al.Systematic review: symptom assessment using patient-reported outcomes in gastroesophageal reflux disease and dyspepsia[J]. Scand J Gastroenterol, 2012, 47(12): 1412-1421.
|
| 12 |
Ponce J, Garrigues V, Agréus L, et al.Structured management strategy based on the Gastro-oesophageal Reflux Disease(GERD)Questionnaire(GerdQ)vs.usual primary care for GERD: pooled analysis of five cluster-randomised European studies[J]. Int J Clin Practice, 2012, 66(9): 897-905.
|
| 13 |
Vakil NB, Halling K, Becher A, et al.Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms[J]. Euro J Gastroenterol Hepatol, 2013, 25(1): 2-14.
|
| 14 |
Gurski RR, da Rosa AR, do Valle E, et al.Extraesophageal manifestations of gastroesophageal reflux disease[J]. J Bras Pneumol, 2006, 32(2): 150-160.
|
| 15 |
Giannini EG, Zentilin P, Dulbecco P, et al.Management strategy for patients with gastroesophageal reflux disease: a comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment[J]. Am J Gastroenterol, 2008, 103(2): 267-275.
|
| 16 |
Shaheen N, Ransohoff DF.Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review[J]. JAMA, 2002, 287(15): 1972-1981.
|
| 17 |
Madanick RD.Extraesophageal presentatios of gastroesophageal reflux disease: where is the science? [J]. Gastroenterol Clin North Am, 2014, 43(1): 105-120.
|
| 18 |
Irwin RS.Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl): 80S-94S.
|
| 19 |
Morice AH, Fontana GA, Sovijarvi AR, et al.The diagnosis and management of chronic cough[J]. Europe Resp J, 2004, 24(3): 481-492.
|
| 20 |
Kahrilas PJ, Hughes N, Howden CW.Response of unexplained chest pain to PPI treatment in patients w and without objective evidence of gastroesophageal reflux disease[J]. Gut, 2011, 60(11): 1473-1478.
|
| 21 |
Shaheen NJ1, Weinberg DS, Denberg TD, et al.Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of ACP[J]. Ann Intern Med, 2012, 157(11): 808-816.
|
| 22 |
Poelmans J, Feenstra L, Demedts I, et al.The yield of upper gastrointestinal endoscopy in patients with suspected reflux-related chronic ear, nose, and throat symptoms[J]. Am J Gastroenterol, 2004, 99(8): 1419-1426.
|
| 23 |
Dent J, El-Serag HB, Wallander MA, et al.Epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2005, 54(5): 710-717.
|
| 24 |
El-Serag HB, Sweet S, Winchester CC, et al.Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review[J]. Gut, 2014, 63(6): 871-880.
|
| 25 |
Jung HK.Epidemiology of gastroesophageal reflux disease in Asia: a systematic review[J]. J Neurogastrol Motil, 2011, 17(1): 14-27.
|
| 26 |
Gunaratnam NT, Jessup TP, Inadomi J, et al.Sub-optimal PPI dosing is prevalent in patients with poorly controlled gastroesophageal reflux disease[J]. Aliment Pharmacol Ther, 2006, 23(10): 1473-1477.
|
| 27 |
El-Serag HB.Epidemiology of non-erosive reflux disease[J]. Digestion, 2008, 78(Suppl 1): 6-10.
|
| 28 |
Taylor JB, Rubenstein JH.Meta-analyses of effect of symptoms of GASTROESOPHAGEAL REFLUX DISEASE on the risk of Barrett′s esophagus[J]. Am J Gastroenterol, 2010, 105(8): 1729-1737.
|
| 29 |
Rubenstein JH, Taylor JB.Mata-analysis: the association of oesophageal adenocarcinoma with symptoms of gastroesophageal reflux disease[J]. Aliment Pharm Ther, 2010, 32(10): 1222-1227.
|
| 30 |
Hirota WK1, Zuckerman MJ, Adler DG, et al.ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the the upper GI tract[J]. Gastrointest Endosc, 2006, 63(4): 570-580.
|